There are much broader implications beyond my unprofitable venture into cannabis stocks.
These names provide exposure to the cannabis industry, but also pay hefty dividends to shareholders.
It would be foolish to ignore the Fed chairman, who could sneeze and turn everyone bearish.
Meanwhile, the market indexes remain on cruise control as traders await Jerome Powell's utterances at Jackson Hole.
It seems to me that federal legislation is inevitable.
The ETF is showing signs of perking up and the micro-cap is a maker of electric outboard motors.
The risk/reward profiles of AGFY and MAP are enticing.
Tech stocks didn't disappear after the dot-com bubble; the cream of the crop came back healthier than ever. And so will the best-run cannabis stocks.
Shares of the cannabis company have provided a rude awakening for buy-and-hold investors.
The same can be said of cannabis stocks as fresh talk of federal legislation to legalize marijuana likely is just that… talk.
I have my eye on relative strength in groups that have lagged for a very long time.
Many stocks are very oversold, and sentiment is about as bad as it gets.
Here we'll hash out the differences among cannabis players and see high how Roundhill Investment's The Cannabis ETF can go.
Pressure on fertilizer supplies due to sanctions against Russia because of the war in Ukraine makes the potash producer a star performer in a down market.
Tilray is okay in my book for speculation.
There should be some better trading action and setups as things pull back.
It isn't brave to trade without a game plan; it's foolhardy and can result in big losses.
Small-caps and growth names are relatively weak.
Let's check out the 21-day exponential moving averages of SPY and QQQ for clues and also look at three stocks for trading ideas.
While performance hasn't been mind blowing so far, psychedelics are where cannabis was a decade or so ago.
I'm looking at a possible inverse head and shoulders forming on many cannabis charts.
Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.
They range from doing nothing to jumping into the day-trading fray.
TLRY posted promising earnings, but don't expect it smoke past its current levels for long.
You think the Tilray brand name is worth $2.8B? Market cap is barely above $3B. Does give me pause.
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
The broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging. From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride.
And there are a few ETFs and a silver miner that could provide the vehicles to play this hunch.
Will these exchange-traded funds pay off or send your portfolio up in a 'PUF'?
We're in good shape for a continuation of the upside action next week.